Sterile Cleanroom Wipes - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Sterile Cleanroom Wipes

VAI’s Sterile Cleanroom Wipes use innovative manufacturing technologies, and the single source dedicated supply chain allow for the vertical manufacturing process to be completely traceable from start to finish.

VAI’s wipes are knitted with continuous monofilament polyester and are cut using a “focused edge” cutting technology. This eliminates the risk of particulates being introduced into classified areas, by improving the edge over traditional laser cutting.

All wipes are quality assurance tested and released to specifications defined by IEST and ASTM methods.

VAI’s wipes are made with one material (dry or saturated) for easy inexpensive validation and consistency throughout your manufacturing areas.  All versions of dry or saturated wipes are manufactured under cGMP’s, are lot traceable and validated.

VAI’s high quality wipes are available in WipeDown® dry wipes, Procees2Wipe® (USP IPA and WFI Quality Water), HYPO-CHLOR® WFI formula in 0.25%, 0.52%, and 5.25%, STERI-PEROX® WFI formula 3% and 6%, DECON-Clean® RTU residue remover, individually packaged Alcoh Wipes®, STEEL-BRIGHT® Wipes and DAS® Wipes.



blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here